Genetic and epigenetic networks in cognitive dysfunctio
Recruiting
- Conditions
- autismecognitive disabilitycognitive dysfunction1002766410057167
- Registration Number
- NL-OMON36002
- Lead Sponsor
- niversitair Medisch Centrum Sint Radboud
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 10000
Inclusion Criteria
cognitive dysfunction
Exclusion Criteria
nvt
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>reeds in bezit</p><br>
- Secondary Outcome Measures
Name Time Method <p>reeds in bezit</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What genetic-epigenetic interactions underlie cognitive dysfunction in autism spectrum disorder and intellectual disabilities?
How do epigenetic markers in GENCODYS trial compare to standard neuropsychological assessments for predicting cognitive outcomes?
Which DNA methylation or histone modification biomarkers correlate with severity of cognitive disability in the NL-OMON36002 cohort?
What are the potential risks of invasive epigenetic profiling in large-scale cognitive dysfunction studies like GENCODYS?
What novel molecular targets for cognitive enhancement emerge from genetic network analysis in the autism and 10027664 patient populations?